|
End-of-day quote
LUXEMBOURG S.E.
13/08/2026
|
5-day change | 1st Jan Change | ||
| 15.30 USD | 0.00% |
|
-1.29% | -8.93% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
Chart: Technical Analysis
Stock exchange
LUXEMBOURG S.E.
CIPLA 15.30 $
0.00%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NSE India S.E.
| CIPLA | 1,451.00INR | -0.53% | 835M ₹ | |
Bombay S.E.
| CIPLA | 1,452.20INR | -0.60% | 29.07M ₹ | |
LUXEMBOURG S.E.
| CIPLA | 15.30USD | 0.00% | 0 $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CIPLA Stock
- CIPLA Stock
- Charts Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
